The bone marrow biopsy specimens of 35 patients with benign and malignant erythroid hyperplasias were examined for the presence of hemoglobin A, hemoglobin F, muramidase (lysozyme), and transferrin, using an indirect immunoperoxidase method (PAP) on Zenker's-fixed paraffin-embedded bone marrow biopsy specimens and particles. Five cases of each of the following entities were studied: erythroleukemia and erythremic myelosis, acute granulocytic leukemia with maturation (FAB M2), polycythemia rubra vera, myeloproliferative syndrome in childhood, megaloblastic anemia (B, 2 and folate deficiency), erythroid hyperplasia (regenerating bone marrow and hemolytic anemia), and Ph' chromosome positive chronic granulocytic leukemia. Hemoglobin A was present in both the early and late erythroid precursors in all conditions. Hemoglobin F was the predominant hemoglobin in early erythroblasts of pernicious anemia and in both early and late erythroid elements in erythroleukemia and erythremic myelosis. Small quantities of hemoglobin F were present in a few isolated clusters in other conditions. Staining for hemoglobin F may be useful in identifying immature erythroid precursors and in distinguishing some cases of dysplastic erythroid hyperplasia from neoplasia. Additionally, these findings suggest that the maturational switch in hemoglobin synthesis operates with distinct pathways under different conditions. (Key words: Immunoperoxidase; Hb A; HbF; Erythremic myelosis; Erythroleukemia; Erythroid hyperplasia) Am J Clin Pathol 1983; 80: 145-151 SEVERAL RECENT PUBLICATIONS have reported the use of immunologic methods for intracellular hemoglobin, muramidase, and transferrin in the assessment of hematopoiesis and myeloproliferative diseases. Such technics permit identification and study of the distribution of these proteins in peripheral blood, bone marrow, thymus, and other tissues, and have facilitated the distinction of erythroid elements from other immature precursors cells, including myeloid elements, and from cells of the lymphoid series. 8,9,10 ' 12,14 ' 15 These immunologic methods provide alternatives to the physicochemical technics used in the demonstration of he-moglobin within cell homogenates and fluids [2] [3] [4] [5] [6] and avoid some of the artifacts produced by the acid elution method. 616 In contrast to immunofluorescence, immunoperoxidase methods permit detailed study of the morphologic features of those cells containing the antigenic protein and provide a permanent stained preparation for analysis of the pattern of immunologic staining in relation to the histologic and cytologic features. This report describes an immunohistologic study of a group of hematologic disorders in which erythroid precursors appeared as a prominent feature within a hyperplastic bone marrow. Immunoperoxidase stains for hemoglobin A (Hb A), hemoglobin F (Hb F), muramidase (lysozyme) and transferrin were performed on Zenker's-fixed bone marrow sections. Our findings suggest that immunostaining for Hb A and Hb F may be of value in the differential diagnosis of erythroid hyperplasia versus erythroid neoplasia. In addition, this technic should be useful in exploring the mechanisms of hemoglobin switching 1 ' in normal erythropoiesis.
Materials and Methods
All tissues samples were retrieved from the files of the Hematopathology Section, Los Angeles County Hospital, LAC-USC Medical Center, in accordance with the ethical standards established by the Medical Center and with the Helsinki Declaration of 1975. Cases were selected from bone marrows reviewed in 1981, with the addition of three cases of erythroleukemia retrieved over the past decade (erythroid malignancy accounted for less than 2% of all acute leukemias 1972-1981). Bone marrow biopsy specimens (17 samples) and particles (18 samples) were fixed in Zenker's fixative for 4-6 hours. Core biopsy specimens were decalcified with acetic acid for 2 hours 7 and then processed routinely. Tissue sections were cut at 3-5 n and were de-Zenkerized with 1 % iodine solution. Immunoperoxidase studies were performed utilizing the basic PAP (peroxidase antiperoxidase) method as described in detail elsewhere. 13 Controls consisted of B-5 fixed, paraffin-embedded sections of 20week fetal liver, as well as the internal controls provided by the simultaneous staining of bone marrow sections from the different entities with four different antibodies or PAP reagent alone. The antisera against hemoglobin A (Hb A) and hemoglobin F (Hb F) were obtained from Behring (Calbiochem, San Diego, CA). The specificity was tested by the manufacturer using Immunoelectrophoresis, and cross-reactivity was not found by double immunodiffusion. These antibodies were tested extensively in our laboratory on human biopsy materials without any evidence of cross-reactivity (i.e., antibodies against hemoglobin A and against hemoglobin F produced distinctly different patterns of staining on biologic materials). Antisera against transferrin and muramidase were obtained from DAKO (Santa Barbara, CA); these proved to be specific in previous studies. 8, 9 Swine antirabbit immunoglobulin and PAP complex also were obtained from DAKO. Complete immunostaining kits containing these specific primary antibodies and all other necessary reagents became available during the course of this study (Histosets, Immulok, Carpinteria, CA); these have performed as expected in parallel studies in our laboratories.
Diagnosis of the different diseases was established on bone marrow samples, using PAS-stained tissue sections and Wright-stained smears. The diagnoses were correlated with biochemical assays for serum vitamin B 12 and folate, with chromosome studies for Philadelphia chromosome, and with the patient's hematologic course. The criteria for granulocytic leukemia with maturation and for erythroleukemia followed the standard French-American-British (FAB) criteria 3 : diagnosis was augmented by cytochemical stains performed at the time of initial diagnosis on bone marrow smears and these stains included ferroferricyanide, PAS with and without diastase, peroxidase, chloroacetate esterase, nonspecific esterase, and Sudan black. 3 We specifically did not employ the criteria of Dameshek for Di Guglielmo syndrome. 4 Sections immunostained for hemoglobin A and hemoglobin F were scored according to the number of positive erythroid cells as follows:
(+) scattered cells or single clusters (++) scattered clusters (+++) from one-third to two-thirds of morphologically recognizable erythroid elements (++++) more than two-thirds of erythroid elements
The intensity of the staining also was graded: low (1), medium (m), or high (h) according to the intensity of brown color and definition of staining in the cytoplasm. The positive cells also were classified by nuclear maturation as early (E) (vesicular nucleus and nucleoli), intermediate (M) (neither early or late), and late (L) (condensed chromatin). This scoring system proved useful and reproducible in correlating positive staining with morphology and in separating the different nosologic entities. Results are given in detail in Table 1 according to the aforementioned scoring system.
Results

Erythremic Myelosis (EM) and Erythroleukemia (EL)
The five patients with erythroid malignancies (patients 1, 2, 3, 4, and 5) showed widespread reactivity for both hemoglobin A and F (Figs. 1 and 2), although Hb F stained a greater number of cells in a more intense manner. In addition, the Hb F positive cells were morphologically large and bizzare, with pleomorphic features ( Fig. 2) . Some of the erythroid proliferating cells showed reactivity for transferrin, but this finding is quite variable from case to case.
Megaloblastic Erythropoiesis
Four patients with pernicious anemia (PA) (patients 6, 7, 8, and 9) had a high percentage of erythroid cells positive for both hemoglobin A (++ to ++++) and hemoglobin F (++ to ++++), the latter in smaller numbers of cells overall and more prominent in the immature erythroblasts. In contrast to the cells present in EM and EL, the erythroid precursors of PA were round and regular without a pleomorphic appearance. Patient 9 showed a striking positivity of many immature elements of erythroid morphology for muramidase. Occasionally, some erythroid elements in the pernicious anemia group showed positivity for transferrin. Such positive reaction was found in less than one-third of the cells and was present in both early and late erythroblasts.
Myeloproliferative Disorders
Hemoglobin A was present in more than two-thirds of erythroid elements in all five cases of polycythemia rubra vera. Hb F was detected in only one patient (patient 32) and then only in a few scattered clusters of cells. In adult chronic granulocytic leukemia (CGL) (five cases) Hb A was detected in more than two-thirds of erythroid precursors: Hb F also was present but was distributed in scattered small clusters of erythroid elements (less than one-third of erythroid precursors). In the pediatric myeloproliferative disorders (five cases) reactivity for both Hb A and F was reduced. In one patient (patient 23) no cells reactive to Hb A were found, 
• Abbreviations: H b A -hemoglobin A: EL = erythroleukemia: B,2 = vitamin Bu deficiency anemia: CGL = chronic granulocytic leukemia; AGL = acute granulocytic leukemia: Hb F -hemoglobin F; EM -erythremic myelosis; fol. = folate deficiency anemia: Ph' • Philadelphia chromosome. t Scoring System: Distribution-+ = scattered cells or single clusters: + + -scattered clusters; + + + = from one-third to two-thirds of erythroid elements: + + + + • more than twothirds of erythroid elements. Intensity-1 = low; m = medium: h -high. Maturation-Eearly (vesicular nucleus and nucleoli); M •= intermediate (neither early or late): L -late (condensed chromatin).
while some Hb F reactive cells were present. The converse was observed in patients 21 and 22 in which no hemoglobin F was detectable.
Acute Granulocytic Leukemia with Maturation (FAB M2)
The predominant staining reaction in acute granulocytic leukemia (AGL) was the staining of granulocytes with muramidase in both early and late precursors. Hemoglobin A stained the majority of erythroid precursors, primarily the late normoblasts. Only rare scattered clusters of erythroid elements stained with hemoglobin F.
Erythroid Hyperplasia
Four cases of regenerating bone marrow and one of hemolytic anemia were studied. Hb A was positive in most erythroblasts with variable intensity (Fig. 3 ). Only two patients showed evidence of reactivity for hemoglobin F and then in scattered clusters (Fig. 4) .
In summary, while Hb A was detected in all patients but one, Hb F was detected in only 26 out of 35 patients. Erythremic myelosis, erythroleukemia, and megaloblastic erythropoiesis showed widespread and intense Hb F reactivity, including early and late erythroid elements. The remaining cases with non-neoplastic erythroid pro-FlG. 1 (upper) . Immunostaining for hemoglobin A shows scattered positive cells, mostly maturing erythroblasts (arrows), in erythremic myelosis (patient 4).
FIG. 2 (lower). Erythremic myelosis (patient 4)
: staining for hemoglobin F shows positive erythroblasts in different maturation stages and occasional anaplastic elements (arrows). 149 liferation showed lesser amounts of Hb F positivity, limited primarily to more mature precursors. The immunostaining for these antigens appears to enhance morphologic differences between erythremic myelosis, erythroleukemia, and the other conditions. Staining separation of the megaloblastic anemias is not as clear; however, morphologic differences are helpful in this distinction. Transferrin stained scattered histiophagocytic elements as previously reported, 9 some erythroid elements in erythroleukemia, erythremic myelosis, and pernicious anemia. The staining pattern, while occasionally quite marked, did not provide diagnostic help. Muramidase stained granulocytes and precursors in all cases studied.
Discussion
Cytochemical and physicochemical methods for the detection and quantitation of hemoglobin A and hemoglobin F such as hemoglobin electrophoresis, acidelution, 6 and alkali denaturation, 2 all have proved useful in the diagnosis of hemoglobinopathies and allied diseases. These methods have proved less helpful in the study and differential diagnosis of other hematopoietic disorders, such as pernicious anemia, and in the acute leukemias, in which alterations in Hb F levels are inconstant findings. 2 More sensitive immunologic methods using antibodies directed against the hemoglobin molecule recently have been utilized in the study of normal hemoglobin regulation" and in the evaluation of abnormal erythropoiesis. 16 These procedures permit the detection of minor quantities of hemoglobin A and hemoglobin F in individual erythrocytes 5 and precursors. Immunofluorescent studies, utilizing specific and distinct anti-hemoglobin A and anti-hemoglobin F antibodies (performed on fresh peripheral blood, blood smears, and in vitro bone marrow cultures) have provided insights into the mechanisms of hemoglobin switching in normal and abnormal states but have the same morphologic limitations of the fluorescent techm c 5.H.I6 immunopgroxidase methods have been utilized in only a few investigations 10121415 and have proved to be sensitive detectors of minor quantities of hemoglobin, while allowing simultaneous evaluation of fine histologic and cytologic detail. However, except for a study by one of the authors' 4 (1976) and a recent report by Underwood and Dangerfield, 15 (1981) immunoperoxidase studies to date have utilized anti-human hemoglobin antibodies that do not distinguish between Hb A and Hb F. The intent of this study was to survey a number of bone marrow erythroid proliferations, both benign and malignant, utilizing the PAP immunoperoxidase technic and separate specific antibodies against both hemoglobin A and hemoglobin F, in order to ex-amine the distribution of cells containing Hb A and HbF.
Two distinct patterns of hemoglobin A and hemoglobin F distribution were observed in the various proliferations studied. One pattern, observed in cases of benign erythroid hyperplasia, acute granulocytic leukemia (AGL), chronic granulocytic leukemia (CGL), and other myeloproliferative disorders, is characterized by a wide distribution of Hb A in all stages of erythroid maturation, with Hb F positivity limited to scattered cells or small clusters of predominantly late precursors. The second pattern, observed only in cases of erythremic myelosis, erythroleukemia, and pernicious anemia, is typified by widespread hemoglobin A and hemoglobin F distribution at all levels of maturation (EL or EM), or segregating in the less mature precursors (PA).
These findings are at variance with previous physicochemical studies based mainly on peripheral blood evaluation, in which Hb F elevation is infrequent (less than 5% of cases of PA) and of variable quantity. 2 Peripheral blood hemoglobin electrophoresis performed on two cases of erythremic myelosis in this study revealed a normal hemoglobin profile without elevation in hemoglobin F. The discordance between our uniform findings of Hb F elevation in the bone marrow of PA, EL, and EM and the variable reports in the literature, and the discordance between our bone marrow and peripheral blood findings may have several explanations. The best documented is the high level of ineffective erythropoiesis that characterizes both PA and the acute erythroid malignancies. The Hb F positive erythroid precursors may be incapable of maturation to the level of circulating erythrocytes. Morphologic evidence of karyorrhexis and phagocytosis, are identified easily in these marrows. A second explanation is an alteration in the incompletely understood switching mechanisms controlling Hb F expression in adulthood. Clearly there is a difference in distribution of hemoglobin F and hemoglobin A comparing PA, EM, EL, and the other erythroid hyperplasias. PA has widespread distribution of Hb F in early precursors; other conditions show only occasional clusters. Such early cell death and the separation of nucleated red cells from packed red blood cells would prevent the detection of hemoglobin F on the electrophoresis of peripheral blood. Finally, bone marrow release of red blood cells and precursors into the peripheral blood may vary, according to the degree of marrow fibrosis and surface characteristics of the RBC membrane. In some entities, such as EM and EL, a combination of factors may be operating simultaneously.
The immunoperoxidase technic appears to be a useful tool in recognizing hemoglobin distribution and correlating this with biochemical and molecular studies. The 
FlG. 4 (lower). Regenerating bone marrow: only one cluster (arrow) is positive for hemoglobin F (patient 27).
< uniform appearance of high Hb F positivity in our cases of erythroleukemia and erythremic myelosis is more intriguing in the face of the variable patterns reported in the literature. 2 If this finding persists in a study of additional cases, it may indicate the usefulness of high Hb F positivity as an oncofetal tumor marker 1 similar to alpha fetoprotein (AFP) or carcinoembryonic antigen (CEA). Just as the presence of CEA and AFP is not confined to malignancies, the pattern of hemoglobin F positivity is not unique to the erythroid malignancies, e.g., PA. The bone marrow hemoglobin F pattern seems helpful in distinguishing a morphologically malignant erythroid proliferation from the atypical hyperplasias observed in the regenerating states following chemotherapy and in the myelodysplastic states. In summary, immunoperoxidase methods utilizing specific and distinct antihemoglobin antibodies appear to be a useful tool in the investigation of hemoglobin distribution and in the differential diagnosis of benign and malignant bone marrow erythroid hyperplasias. Combined with physicochemical and cytochemical technics, they may allow the determination of characteristic tissue "hemoglobin profiles" in hyperplastic bone marrows with erythroid predominance.
